Google
PEPG — PEPGEN LTD (Healthcare >> Biotechnology)
PEPG FAQ
What is PEPG's ROE?
PEPGEN LTD reports a Return on Equity (ROE) of -57.63%.
What is PEPG's dividend yield?
PEPGEN LTD offers a dividend yield of 0.00%.
What is PEPG's Deepscope Quality Score?
Deepscope rates PEPG's overall financial quality at 54 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy PEPG?
Deepscope's AI Timing Score for PEPG is 26 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does PEPG belong to?
PEPGEN LTD is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 1.38
Price
0.03
(2.22%)
Day Change
|
|
|---|
PEPG, ファンダメンタルスコアはnot quite good ( ファンダメンタル = 54) そして テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEが低い
ROAが低い
平均ROEが低い
ROAがROEに比べて低い
NPMが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...
| Deepscope 分析 |
|
48% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 96 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 1.38 |
| PBV / Sector |
0.72 / 4.71
GREAT
|
| Earning Per Share | -1.11 |
| PE / Sector |
N/A / 17.58
|
| PEG or PE/Growth / Sector |
N/A / 0.53
|
| Average 1M Daily Value |
1.10 M
GREAT
|
| Average 1W Daily Value |
0.86 M
GREAT
|
| Timing Factors |
|
42% |
| Financial Health |
|
45% |
| ポイントになる統計 |
|
37% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-06-10 09:43:39 |
| Symbol | PEPG |
| Name | PEPGEN LTD |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 69.17 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 96.15 / 8,889.42 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 321 Harrison Avenue, Boston, MA, United States, 02118
Phone: 781 797 0979
Website: https://www.pepgen.com
Employees: 56
Sector: Healthcare >> Biotechnology
Description: PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States. The company engages in the development of PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 2 clinical trial for the treatment of myotonic dystrophy type 1; and FREEDOM2-DM1, which is in Phase 2 for the treatment of myotonic dystrophy type 1. It is also involved in FREEDOM-OLE, an open label expansion study. The company was founded in 2018 and is based in Boston, Massachusetts.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
